Home > Expert Blogs > Diet Write  
About
I am here to report the latest news in diet and fitness for Diet.com. Feel free to give your two cents about the articles I write, or shoot me a message with any diet news that you'd like me to report on!

» Meet DietWrite
» Save Author as Favorite
» See all DietWrite's Posts

Recent Posts

» It's The Great Pumpkin: Recipes & More
» Lacking Nutrients? The Health Risks You Face
» Preventing Breast Cancer: 6 Proven Tips
» Celebrate National Seafood Month!
» Fruit of the Season: Loving On Apples!

Archive

» July 2007
» June 2007
» May 2007
» April 2007
» March 2007
» February 2007

Diet Write
by DietWrite, Diet.com's Diet and Fitness News Reporter

Subscribe to this feed Subscribe

In a news release issued on Wednesday, The Food and Drug Administration announced that the new anti-obesity drug Belviq has been approved. It is the first time in over a decade that the Food and Drug administration has approved a prescription weight-loss drug.

The FDA approved the drug for adults who are obese or who are overweight with a medical complication such as having high blood pressure, high cholesterol or type 2 diabetes.

Belviq works by controlling and suppressing appetite. The drug activates brain receptors that help people feel full sooner. It is intended to be used in combination with a reduced calorie diet and exercise.

In 2010 the FDA chose not to clear Belviq due to concerns about the safety of the drug. However, new data submitted by the drug’s manufacturer, Arena Pharmaceuticals, swayed the FDA to vote for approval.

Common side effects of the drug include, headache, dizziness, fatigue, and back pain.


Post a Comment
  Preview

McAfee SECURE sites help keep you safe from identity theft, credit card fraud, spyware, spam, viruses and online scams